网站主页 >> CAS数据库列表 >> 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
|
|
- CAS号:
- 193551-21-2
- 英文名:
- SB 239063
- 英文别名:
- CS-402;SB 239063;SB-239063; SB239063;SB 239063 - CAS 798558-40-4 - Calbiochem;rans-4-[4-(4-Fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexano;TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE;TRANS-4-[4-(4-FLUOROPHENYL)-5-(2-METHOXY-4-PYRIMIDINYL)-1H-IMIDAZOL-1-YL]CYCLOHEXANOL;TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE;TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIDIMIDIN-4-YL)IMIDAZOLE;Cyclohexanol, 4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]-, trans-
- 中文名:
- 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
- 中文别名:
- 化合物L-779450;反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑;反-4-[4-(4-氟苯基)-5-(2-甲氧基-4-嘧啶基)-1H-咪唑-1-基]环己醇;(1R,4R)-REL-4-(4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)-1H-咪唑-1-基)环己醇
- CBNumber:
- CB6100319
- 分子式:
- C20H21FN4O2
- 分子量:
- 368.4
- MOL File:
- 193551-21-2.mol
|
|
|
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑化学性质
-
熔点:
-
206-207.2 °C
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: 11 mg/mL
-
|
-
形态:
-
White solid
-
|
-
颜色:
-
white
-
|
-
InChIKey:
-
ZQUSFAUAYSEREK-WKILWMFISA-N
-
|
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑性质、用途与生产工艺
SB239063是一种有效的选择性p38 MAPKα/β抑制剂,IC50为44 nM,对γ- 和 δ-激酶亚型没有活性。
Target | Value |
p38α
(Cell-free assay)
|
44 nM
|
p38β
(Cell-free assay)
|
44 nM
|
SB 239063 (0.1–10 μM ; 29 hours, 47 hours) increases apoptosis of eosinophils in a dose-related in the presence of 10 pM IL-5 at every time point from 21 hours onwards.
SB 239063 potently inhibits IL-1 and TNF- a production in LPS-stimulated human peripheral blood monocytes with IC
50
values of 120 nM and 350 nM, respectively.
Apoptosis Analysis
Cell Line:
|
Eosinophils (guinea pig BALs)
|
Concentration:
|
0.1μM, 1μM, 10μM
|
Incubation Time:
|
29 hours, 47 hours
|
Result:
|
Increased apoptosis of eosinophils in a dose-related in the presence of 10 pM IL-5 at every time point from 21 hours onwards.
|
SB 239063 (12 mg/kg; p.o.; 1 hour before and 4 hours after OA challenge; b.i.d. for 3 days) significantly inhibits the resultant antigen-induced airway eosinophilia.
SB 239063 (12 mg/kg; p.o.) almost abolishes ovalbumin (OA)-induced airway eosinophilia (~ 93% inhibition) by inhalation.
SB 239063 is a potent inhibitor of LPS-induced TNF-alpha production in the mouse peritoneal cavity with an EC
50
of 5.8 mg/kg (2.8–10.3; 95% CL).
Animal Model:
|
Male BALB/c mice (18–20 g)
|
Dosage:
|
12 mg/kg
|
Administration:
|
Oral administration; 1 h before and 4 h after OA challenge; bis in die for 3 days
|
Result:
|
Significantly inhibited the resultant antigen-induced airway eosinophilia.
|
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-11068 | 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 SB 239063 | 193551-21-2 | 1mg | 500元 |
2024/04/30 | HY-11068 | 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 SB 239063 | 193551-21-2 | 10mM * 1mLin DMSO | 892元 |
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
生产厂家
193551-21-2, 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 相关搜索:
- Protein Kinase Inhibitors and Activators
- Heterocycles
- Aromatics
- 生化试剂
- Cell Signaling and Neuroscience
- Cell Biology
- BioChemical
- Serine/Threonine Kinase Inhibitors
- Mitogen-Activated Protein Kinase (MAPK)
- Kinase/Phosphatase Biology
- C20H21N4O2F
- 化合物L-779450
- (1R,4R)-REL-4-(4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)-1H-咪唑-1-基)环己醇
- 反-4-[4-(4-氟苯基)-5-(2-甲氧基-4-嘧啶基)-1H-咪唑-1-基]环己醇
- 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
- 193551-21-2
- Rel-(1r,4r)-4-(4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)-1H-imidazol-1-yl)cyclohexan-1-ol
- rans-4-[4-(4-Fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexano
- SB-239063; SB239063
- CS-402
- SB 239063 - CAS 798558-40-4 - Calbiochem
- Cyclohexanol, 4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]-, trans-
- TRANS-4-[4-(4-FLUOROPHENYL)-5-(2-METHOXY-4-PYRIMIDINYL)-1H-IMIDAZOL-1-YL]CYCLOHEXANOL
- TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE
- TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE
- TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIDIMIDIN-4-YL)IMIDAZOLE
- SB 239063